IMP1 expression does not correlate with TP53-mutant or TP53 wild-type PDAC patients (Figure 1C, https://ualcan.path.uab.edu/cgi-bin/TCGAExResultNew2.pl?genenam=IGF2BP1&ctype=PAAD, accessed on 5 September 2023), and a significant increase in IMP1 expression was observed in PDAC patients in tumor stages 1, 2, and 4 (Figure 1D, https://ualcan.path.uab.edu/cgi-bin/TCGAExResultNew2.pl?genenam=IGF2BP1&ctype=PAAD, accessed on 5 September 2023). The gene discussed is IGF2BP1; the disease is neoplasm.